Cargando…
Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRISPR/Cas9 and other genomic editing technologies
Genomic editing technologies are developing rapidly, promising significant developments for biomedicine, agriculture and other fields. In the present investigation, we analyzed and compared the process of innovation for six genomic technologies: viral vectors, RNAi, TALENs, meganucleases, ZFNs and C...
Autores principales: | Fajardo-Ortiz, David, Shattuck, Annie, Hornbostel, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159216/ https://www.ncbi.nlm.nih.gov/pubmed/32294089 http://dx.doi.org/10.1371/journal.pone.0227593 |
Ejemplares similares
-
Aquaculture as a source of empirical evidence for coevolution between CRISPR-Cas and phage
por: Hoikkala, Ville, et al.
Publicado: (2019) -
Intra-embryo Gene Cassette Knockin by CRISPR/Cas9-Mediated Genome Editing with Adeno-Associated Viral Vector
por: Mizuno, Naoaki, et al.
Publicado: (2018) -
CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors
por: Leal, Andrés Felipe, et al.
Publicado: (2022) -
CRISPR/Cas9—Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development
por: Okoli, Arinze, et al.
Publicado: (2018) -
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
por: Najafi, Sajad, et al.
Publicado: (2022)